This week’s research highlights several potential avenues for extending healthspan and reducing dementia risk, from widely used cardiovascular medications and vaccines to lifestyle and dietary interventions that may influence biological aging. New findings continue to reinforce the connections between cardiovascular, metabolic, immune, and cognitive health as we age.
Are you part of a health or life extension research organization? Our coalition has grown to over 90 member groups, including 25 major US organizations and 16 major international groups. We hope your organization will be next! Check below to find a link to join our coalition quickly and easily.
All this and more this week. Join us as we move forward into another exciting month of incredible opportunities in this burgeoning and revolutionary field.
Edwina Rogers, CEO
Global Healthspan Policy Institute
Facebook
Twitter
LinkedIn
Statins Linked to Lower Dementia Risk in Massive Type 2 Diabetes Study
A nationwide Danish study of more than 132,000 people with type 2 diabetes found that beginning statin therapy within a year of diagnosis was associated with a 15% lower relative risk of dementia over 10 years, while starting treatment one to five years after diagnosis was associated with a 10% lower risk.
What Can and Can’t Slow Down Aging: New Study Offers Clues
An analysis of epigenetic aging biomarkers found measurable effects from several dietary, lifestyle, and pharmacological interventions, while commonly used over-the-counter supplements showed little evidence of affecting these markers of biological aging.
Common Vaccine Linked to 24% Lower Dementia Risk in Older Adults
An analysis of health records from more than 509,000 older adults found that those who received at least one dose of the Shingrix shingles vaccine had a 24% lower relative risk of receiving a dementia diagnosis over four years compared with those who were not vaccinated.
Intensive Blood Pressure Control Cuts 7-Year Dementia Risk by 15%, Study Finds
A seven-year study involving nearly 34,000 adults found that a community-based intervention targeting blood pressure below 130/80 mmHg reduced dementia risk by 15% and cognitive impairment by 13% compared with usual care.
